What is the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD‑10‑CM) diagnosis code for intestinal methanogen overgrowth?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10-CM Code for Intestinal Methanogen Overgrowth

There is no specific ICD-10-CM code for intestinal methanogen overgrowth (IMO); use K63.89 (Other specified diseases of intestine) or K90.89 (Other intestinal malabsorption) depending on the clinical presentation.

Understanding the Coding Challenge

Intestinal methanogen overgrowth is a recently recognized distinct entity from small intestinal bacterial overgrowth (SIBO), characterized by overgrowth of methane-producing archaea, specifically Methanobrevibacter smithii 1, 2. The term "IMO" was proposed because these organisms are archaea (not bacteria) and can overgrow outside the small intestine 1.

Recommended Coding Approach

Primary Code Options:

  • K63.89 (Other specified diseases of intestine) - Use this code when IMO presents primarily with gastrointestinal symptoms such as abdominal pain, distension, and bloating without significant malabsorption 3

  • K90.89 (Other intestinal malabsorption) - Use this code when IMO presents with malabsorption features including deficiency of fat-soluble vitamins, vitamin B12, or iron deficiency anemia 3, 2

Clinical Context for Code Selection:

  • If the patient has documented malnutrition, vitamin deficiencies (B12, fat-soluble vitamins), or iron deficiency anemia, K90.89 is more appropriate 3, 2

  • If the patient presents primarily with functional symptoms (constipation, bloating, abdominal pain) without malabsorption, K63.89 is more appropriate 3, 1

Important Coding Considerations

Documentation Requirements:

  • Document the diagnostic method used (breath testing showing elevated methane levels ≥10 ppm is diagnostic for IMO) 4, 5

  • Note associated symptoms: IMO typically presents with constipation rather than diarrhea, distinguishing it from hydrogen-producing SIBO 3, 1

  • Record any nutritional deficiencies or malabsorption findings to support code selection 3, 2

Common Pitfall:

  • Do not use K90.4 (Malabsorption due to intolerance) - This code is reserved for specific intolerances (lactose, fructose, etc.) and does not accurately represent IMO 3

  • Avoid using unspecified codes when clinical documentation supports a more specific diagnosis - always choose between K63.89 or K90.89 based on the clinical presentation 3

Related Questions

What biofilm disruptors are most effective for intestinal methanogen overgrowth (IMO)?
Can high blood pressure be a sign of dehydration in a patient undergoing antimicrobial treatment for intestinal methanogen (methane-producing microorganism) overgrowth without diarrhea?
Do fat-soluble vitamins (A, D, E, and K) deplete as quickly as vitamin B12 in a patient with a history of Small Intestine Bacterial Overgrowth (SIBO) and methane and hydrogen SIBO?
What is the role of berberine in treating a patient with Small Intestine Bacterial Overgrowth (SIBO) with methane-producing bacteria?
What are the recommended biofilm disruptors for treating intestinal methanogen overgrowth?
In a patient with bilateral leg pain that occurs after sexual activity (masturbation) and has normal laboratory, neurologic, and vascular studies, what is the most appropriate next step in management?
What is the appropriate evaluation and management for a patient presenting with generalized progressive myalgia and weakness?
Is the genital numbness I'm experiencing while on a selective serotonin reuptake inhibitor (SSRI) due to pudendal nerve pathology?
Is the genital numbness I'm experiencing a cutaneous sensory effect of my selective serotonin reuptake inhibitor (SSRI) rather than pudendal nerve pathology?
Can digoxin be used in a patient with atrial fibrillation and hypotension?
In a patient who recently underwent surgery, does exogenous testosterone affect wound healing or increase thrombosis risk, and should it be held perioperatively?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.